Hainan Island’s Special Access Program for Medical Devices

Published on: August 1st, 2024

On May 1, 2023, Hainan Province reaffirmed its special access program to for the importation of urgently needed drugs and medical devices into the Boao Lecheng International Medical Tourism Pilot Zone. This allows the clinical use of qualified overseas medical devices that have not received NMPA approval if they are clinically essential and lack alternatives.

Medical Devices that Qualify for the Hainan Special Access Program:

Devices must meet one of the following criteria

  • Address a clinically urgent need.
  • Treat rare diseases.
  • Prevent or treat serious life-threatening diseases with no existing effective treatment.
  • Offer significant clinical advantages for serious life-threatening diseases.
  • Feature major technological innovations with superior performance.
  • Be approved by the Hainan health administrative authority.

Application Process: Applications must be submitted through one of the 28 hospitals in the Pilot Zone. Initial steps include contacting potential hospitals and forming agreements. A flow chart outlining the application procedure is attached. A distributor in China should find a suitable hospital and establish an agreement, after which Asia Actual can assist with the application process.

Boao Lecheng International Medical Pilot Zone Program: The Hainan special access program provides access to 28 state-of-the-art hospitals currently operational with more under construction. Approval under this program allows products to be sold in these hospitals without NMPA registration.

Asia Actual’s regulatory experts in Beijing are available to assist overseas medical device manufacturers to understand and navigate the clinical data requirement for medical device registration in China. Contact us with any questions for support requests.

Blog Posts

Hainan Island’s Special Access Program for Medical Devices

On May 1, 2023, Hainan Province reaffirmed its special access program to for the importation of urgently needed drugs and medical devices.
Clinical Evaluations in China

China Updates Medical Device Clinical Evaluation Pathway Guidance

In March of 2024, the CMDE added 25 devices to the “Guidelines for Deciding Whether to Conduct Clinical Trials on Medical Devices".
Medical Device Standard Updates in China

China Releases New List of Standards for Medical Device Registration

The NMPA has released the 2024 revised edition of the "List of Mandatory Standards Applicable to Medical Device Products.